absent. The state of California recently added the new long-awaited requirements that stipulate all Cannabis products must be sold in child-resistant packaging and must be lab-tested for potency for a variety of contaminants to include mold & E-coli. Additionally, edibles will be limited to 100mg of THC per package, divided into 10mg servings. Like most of the legal states, California is not taking the risk of the public becoming ill taking untested cannabinoid / Cannabis products.
The public for the most part, may have had no idea the Cannabis they were purchasing prior was untested and hence some of the apprehension regarding the product; cannabinoids, edibles, vape, smoke, salves, and ointments. Who is looking out for the consumer? How is the product being delivered and by who? Have the products been tested? Where are the relevant case studies? (Halperin, 2018).
On the financial side, the new California requirements were a stab
to the gut to those in the California Cannabis industry because about $350 million worth of Cannabis products could be destroyed as new regulations took effect on Sunday in California on June 30, 2018. Any Cannabis product untested and not sold prior to the June date had to be destroyed. Should this concern the doctors, oncologists and scientists? Specifically, those that have already been offering Cannabis to patients within the treatment plan?
to patients within their treatment plan? Many interested in the medicinal Cannabis industry say yes, it does and should. The Cannabinoid program Dr. Padma-Nathan hosted left many attendees with additional questions but in cannabinoid medicine maybe that’s a good thing and the start of continuous communication between those that will prescribe and deliver to the consumer.
34 35